Skip to main content

Table 4 Risk for cardiovascular outcomes or cardiovascular mortality

From: Prognostic value of non-specific ST-T changes and left ventricular hypertrophy electrocardiographic criteria in hypertensive patients: 16-year follow-up results from the MINACOR cohort

 

HR [95% CI] adjusted for gender, age, SBP, DM2 incidence, major or minor ECG abnormalities and smoking

P -value

Crude HR [95% CI]

P -value

Major or minor ECG abnormalities

0.97 [0.49 -1.90]

0.923

1.33 [0.69 - 2.54]

0.387

Gender (Male)

1.08 [0.59 - 1.96]

0.804

1.18 [0.73 - 1.90]

0.491

Age

1.07 [1.03 - 1.12]

0.002

1.07 [1.02 - 1.11]

0.003

SBP

1.01 [1.00 - 1.03]

0.053

1.02 [1.00 - 1.03]

0.022

DM incidence

1.97 [1.21 - 3.20]

0.006

2.08 [1.30 - 3.30]

0.003

Smoking

1.98 [1.06 - 3.70]

0.032

1.71 [1.05 - 2.80]

0.033

  1. LVH, Left Ventricular Hypertrophy; HR: Hazard Ratio; SBP, Systolic Blood Pressure; DM: Type 2 Diabetis; CI, confidence interval.
  2. Hazard ratios were estimated using proportional hazards (Cox) regression modeling with major or minor electrocardiographic (ECG) abnormalities.